Literature DB >> 850321

Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero.

W B Gill, G F Schumacher, M Bibbo.   

Abstract

The in utero effects of diethylstilbestrol on the human male genital tract are reported in our followup study of male offspring of mothers treated with diethylstilbestrol. Anatomical and functional abnormalities were significantly greater in male patients exposed to diethylstilbestrol compared to male controls whose mothers were all participants in a prospective, randomized double-blind study on the effects of diethylstilbestrol on pregnancy at our hospital during the early 1950s. Epididymal cysts, hypotrophic testes and capsular induration of the testes were among the more common genital lesions found in more than 25 per cent of 159 male patients exposed to diethylstilbestrol compared to a 6.8 per cent incidence in 161 male controls. Spermatozoal analysis revealed severe pathological changes (Eliasson score more than 10) in 32 per cent of 31 patients exposed to diethylstilbestrol and 0 per cent of 20 male controls. Abnormal findings on physical examination combined with severe sperm abnormalities (Eliasson score more than 10) were found in 23 per cent of the male patients exposed to diethylstilbestrol versus none of the male controls. Cytologic examinations revealed no malignant cells from urine samples before and after prostatic massage or ejaculation, prostatic fluids and aspirates from epididymal cysts.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850321     DOI: 10.1016/s0022-5347(17)58502-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Iatrogenic damage to male reproductive function.

Authors:  W F Hendry
Journal:  J R Soc Med       Date:  1995-10       Impact factor: 5.344

Review 2.  Male reproductive health and environmental xenoestrogens.

Authors:  J Toppari; J C Larsen; P Christiansen; A Giwercman; P Grandjean; L J Guillette; B Jégou; T K Jensen; P Jouannet; N Keiding; H Leffers; J A McLachlan; O Meyer; J Müller; E Rajpert-De Meyts; T Scheike; R Sharpe; J Sumpter; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

3.  Neonatal exposure to coumestrol, a phytoestrogen, does not alter spermatogenic potential in rats.

Authors:  C A Awoniyi; D Roberts; V Chandrashekar; D N Veeramachaneni; B S Hurst; K E Tucker; W D Schlaff
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

4.  Randomised trial of high doses of stilboestrol and ethisterone therapy in pregnancy: long-term follow-up of the children.

Authors:  V Beral; L Colwell
Journal:  J Epidemiol Community Health       Date:  1981-09       Impact factor: 3.710

5.  Accelerated differentiation in seminiferous tubules of fetal mice prenatally exposed to ethinyl estradiol.

Authors:  Y Yasuda; H Konishi; T Matuso; T Tanimura
Journal:  Anat Embryol (Berl)       Date:  1986

6.  Estrogens and development of the rete testis, efferent ductules, epididymis and vas deferens.

Authors:  Rex A Hess; Richard M Sharpe; Barry T Hinton
Journal:  Differentiation       Date:  2020-12-13       Impact factor: 3.880

Review 7.  Critical windows of exposure for children's health: the reproductive system in animals and humans.

Authors:  J L Pryor; C Hughes; W Foster; B F Hales; B Robaire
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

8.  Maternal hormone levels in early gestation of cryptorchid males: a case-control study.

Authors:  L Bernstein; M C Pike; R H Depue; R K Ross; J W Moore; B E Henderson
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

Review 9.  Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes.

Authors:  A A Bamigboye; J Morris
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 10.  Sperm, a source of estrogen.

Authors:  R A Hess; D Bunick; J M Bahr
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.